Literature DB >> 25582947

Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy.

Ermelinda Pennacchini1, Maria Beatrice Musumeci, Stefano Fierro, Pietro Francia, Camillo Autore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25582947      PMCID： PMC8032077          DOI： 10.1111/jch.12481

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

Review 2.  From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.

Authors:  Alan H Gradman; Fadi Alfayoumi
Journal:  Prog Cardiovasc Dis       Date:  2006 Mar-Apr       Impact factor: 8.194

3.  Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening.

Authors:  J F Lewis; B J Maron
Journal:  Am J Cardiol       Date:  1990-04-01       Impact factor: 2.778

4.  Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy.

Authors:  Valentina O Puntmann; Cosima Jahnke; Rolf Gebker; Bernhard Schnackenburg; Kevin F Fox; Eckart Fleck; Ingo Paetsch
Journal:  Am J Cardiol       Date:  2010-08-11       Impact factor: 2.778

5.  Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.

Authors:  P A Thürmann; P Kenedi; A Schmidt; S Harder; N Rietbrock
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

6.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

7.  Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.

Authors:  D D Savage; J I Drayer; W L Henry; E C Mathews; J H Ware; J M Gardin; E R Cohen; S E Epstein; J H Laragh
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

8.  Hypertensive hypertrophic cardiomyopathy of the elderly.

Authors:  E J Topol; T A Traill; N J Fortuin
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245
  8 in total
  1 in total

1.  Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI.

Authors:  Szu-Ying Tsai; Shan-Ying Wang; Yu-Chien Shiau; Yen-Wen Wu
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.